
News|Articles|February 13, 2019
- Drug Topics March 2019
- Volume 163
- Issue 3
Xofluza for Acute Uncomplicated Influenza
Author(s)Drew Boxler
Advertisement
Xofluza (baloxavir marboxil, Genetech)
Indications: acute uncomplicated influenza in patients 12+, <48hr symptomatic
Dosage:
- 40-80kg body = 40 mg
- 80kg+ = 80 mg
Contraindications: history of hypersensitivity to baloxair marboxil or any of its ingredients
Articles in this issue
over 6 years ago
Coping with Patient Deathover 6 years ago
Opinion: Why Change Is Like a Hemorrhoidectomyover 6 years ago
Pharmacists Want More Time with Patientsover 6 years ago
The Pros and Cons of Switching to a Health Systemover 6 years ago
Early Planning is Key to Retirement and Successionalmost 7 years ago
Dietary Supplements Need Evidence and Evaluationalmost 7 years ago
Reconnect to Reinvigoratealmost 7 years ago
Pharmacy Education for the 21st Centuryalmost 7 years ago
How to Achieve Balance in Work and in Lifealmost 7 years ago
Case Studies in StabilityNewsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Pharmacist’s Expertise in Managing Pneumococcal Diseases, Vaccines
2
What TrumpRx Means for Independent Pharmacies and Their Patients
3
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
4
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
5






























































































































